Botox Market Segmentation
Botox Application Outlook (USD Billion, 2018-2032)
Botox Type Outlook (USD Billion, 2018-2032)
Botox End-user Outlook (USD Billion, 2018-2032)
Botox Regional Outlook (USD Billion, 2018-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BOTOX MARKET, BY APPLICATION
6.1. Overview
6.2. Therapeutics
6.2.1. Chronic Migraine
6.2.2. Spasticity
6.2.3. Overactive Bladder
6.2.4. Cervical Dystonia
6.2.5. Blepharospasm
6.2.6. Others
6.3. Aesthetics
7. GLOBAL BOTOX MARKET, BY TYPE
7.1. Overview
7.2. Botulinum Toxin Type A
7.3. Botulinum Toxin Type B
8. GLOBAL BOTOX MARKET, BY END-USER
8.1. Overview
8.2. Specialty & Dermatology Clinics
8.3. Hospitals & Clinics
8.4. Others
9. GLOBAL BOTOX MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Botox Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Botox Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. AbbVie Inc. (U.S.)
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Lanzhou Institute of Biological Products Co., Ltd. (China)
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Ipsen Pharma (France)
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Merz Pharma (Germany)
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Medytox (South Korea)
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. GALDERMA (Switzerland)
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. HUGEL, Inc. (South Korea)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Evolus, Inc. (U.S.)
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Revance Therapeutics, Inc. (U.S.)
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Supernus Pharmaceuticals, Inc. (U.S.)
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BOTOX MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL BOTOX MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 US: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 10 US: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 US: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 12 CANADA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 CANADA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 CANADA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 10 ITALY: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 ITALY: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 ITALY: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 16 UK: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 UK: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 UK: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 28 CHINA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 CHINA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 30 CHINA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 31 INDIA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 INDIA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 33 INDIA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BOTOX MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BOTOX MARKET
FIGURE 4 GLOBAL BOTOX MARKET, SHARE (%), BY APPLICATION, 2021
FIGURE 5 GLOBAL BOTOX MARKET, SHARE (%), BY TYPE, 2021
FIGURE 6 GLOBAL BOTOX MARKET, SHARE (%), BY END-USER, 2021
FIGURE 7 GLOBAL BOTOX MARKET, SHARE (%), BY REGION, 2021
FIGURE 8 NORTH AMERICA: BOTOX MARKET, SHARE (%), BY REGION, 2021
FIGURE 9 EUROPE: BOTOX MARKET, SHARE (%), BY REGION, 2021
FIGURE 10 ASIA-PACIFIC: BOTOX MARKET, SHARE (%), BY REGION, 2021
FIGURE 11 REST OF THE WORLD: BOTOX MARKET, SHARE (%), BY REGION, 2021
FIGURE 12 GLOBAL BOTOX MARKET: COMPANY SHARE ANALYSIS, 2021 (%)
FIGURE 13 ABBVIE INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ABBVIE INC. (U.S.): SWOT ANALYSIS
FIGURE 15 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD. (CHINA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD. (CHINA): SWOT ANALYSIS
FIGURE 17 IPSEN PHARMA (FRANCE): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 IPSEN PHARMA (FRANCE): SWOT ANALYSIS
FIGURE 19 MERZ PHARMA (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MERZ PHARMA (GERMANY): SWOT ANALYSIS
FIGURE 21 MEDYTOX (SOUTH KOREA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 MEDYTOX (SOUTH KOREA): SWOT ANALYSIS
FIGURE 23 GALDERMA (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 GALDERMA (SWITZERLAND): SWOT ANALYSIS
FIGURE 25 HUGEL, INC. (SOUTH KOREA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 HUGEL, INC. (SOUTH KOREA): SWOT ANALYSIS
FIGURE 27 EVOLUS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 EVOLUS, INC. (U.S.): SWOT ANALYSIS
FIGURE 29 REVANCE THERAPEUTICS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 REVANCE THERAPEUTICS, INC. (U.S.): SWOT ANALYSIS
FIGURE 31 SUPERNUS PHARMACEUTICALS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 SUPERNUS PHARMACEUTICALS, INC. (U.S.): SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
